Turing Labs is a technology company.
Turing Labs has raised $19.0M across 2 funding rounds.
Turing Labs has raised $19.0M in total across 2 funding rounds.
Turing Labs has raised $19.0M in total across 2 funding rounds.
Turing Labs's investors include 20VC, Alumni Ventures, David Ibnale, Bascom Ventures, Better Tomorrow Ventures, Buckley Ventures, Canaan Partners, James Hardiman, Felix Capital, Indus Valley Capital, Infinite Capital, Insight Partners.
Turing Labs Inc. is a Y Combinator-backed AI platform that accelerates R&D for consumer packaged goods (CPG) brands, enabling 10x faster product development from ideation to market-ready formulations.[2][3][4][5] It serves major enterprises like P&G, Unilever, Coke, Nestle, Clorox, Smuckers, and Kraft by analyzing vast datasets on market trends, consumer feedback, ingredients, and regulations to predict preferences, optimize formulas, and minimize failed launches.[2][4] The platform solves the core problem of lengthy, costly R&D cycles—often years of trial-and-error—by providing AI-powered formulation intelligence that turns business goals into viable products in weeks, with features like rapid prototyping, continuous learning from feedback, and global team collaboration.[3][5] Backed by investors including Eric Ries, Turing Labs has raised $19M, scaled to Series A, and grown to an 18-person team in San Francisco.[3][4]
Founded in 2019 by Manmit Shrimali, who serves as CEO, Turing Labs emerged from Winter 2020 Y Combinator (Batch W20).[4] Shrimali, a parent of two with expertise in enterprise sales and category-creating software, independently raised $19M and led sales to global giants before scaling to Series A, drawing from lessons in conflict resolution and high-stakes deal-making.[4] The idea stemmed from the inefficiencies in CPG R&D—complex, expensive processes like developing products for Dove or similar, where companies sift through millions of data points manually.[2][4] Early traction came via founder-led deals with top enterprises, transforming siloed data and repeated experiments into an AI system that compounds institutional knowledge for faster execution.[3][5] Key team members include a CTO, Chief of AI, and executives in technology transformation, strategy, and personal care.[3]
(Note: Search results mention distinct "Turing" entities in frontier AI acceleration [1] and general AI implementation [6], but core details align on Turing Labs Inc. as the CPG R&D specialist.[2][3][4][5])
Turing Labs rides the AI-for-enterprise-R&D wave, capitalizing on generative AI's maturation to automate "art and science" of formulation amid rising consumer demands for healthier, personalized CPG products.[2][3][5] Timing is ideal as CPG giants face pressure from fast-changing trends—shortened shelf lives, sustainability mandates, and data explosion—where traditional R&D lags, costing years and resources.[2][3] Market forces like AI's predictive accuracy (e.g., consumer preference forecasting) and integration with regulatory data favor Turing, enabling safer, higher-satisfaction launches while competitors build in-house slowly.[2][5] It influences the ecosystem by de-risking innovation for incumbents like Unilever/Procter & Gamble, compounding knowledge to shift winners from "best ideas" to "fastest executors," and setting a model for vertical AI in physical goods R&D.[3][4]
Turing Labs is poised to dominate CPG AI R&D as enterprises prioritize execution speed in a post-AGI era, potentially expanding beyond formulations to supply chain and personalization. Trends like multimodal AI, agentic workflows, and regulatory AI (e.g., FDA acceleration) will amplify its edge, with Series A momentum suggesting deeper integrations and global scaling. Its influence may evolve from niche accelerator to ecosystem standard, empowering brands to outpace agile DTC rivals—proving that in CPG, AI doesn't just analyze data; it ships winning products.[3][4][5]
Turing Labs has raised $19.0M across 2 funding rounds. Most recently, it raised $17.0M Series A in January 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2022 | $17.0M Series A | 20VC, Alumni Ventures, David Ibnale, Bascom Ventures, Better Tomorrow Ventures, Buckley Ventures, Canaan Partners, James Hardiman, Felix Capital, Indus Valley Capital, Infinite Capital, Insight Partners, Invariantes Fund, Moment Ventures, Root Ventures, Tet Ventures, Tribe Capital, Unusual Ventures, Alper Kiresepi, Bob Pasker, Clark Landry, Colin Carrier, Curtis Lee, Greg Schroy, Kurt Bilafer, Marco A. Casas, Sahin Boydas | |
| Jul 1, 2020 | $2.0M Seed | Alumni Ventures, David Ibnale, Bascom Ventures, Better Tomorrow Ventures, Felicis Ventures, Footwork, GreaterGoodSociety, Infinite Capital, Invariantes Fund, Moment Ventures, Tribe Capital, Unusual Ventures, UpHonest Capital, Victress Capital, Clark Landry, Grace Chou, Kurt Bilafer, Marco A. Casas, Sahin Boydas |